Sara J Buhrlage

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Topics

Epstein Barr Virus

Capillary Electrophoresis

Epidermal Growth Factor Receptor

Top Venues

Nature communications

Analytical chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Hildo C Lantermans, Fangxue Ma, Annemieke Kuil, Sanne van Kesteren, Sevtap Yasinoglu, Guang Yang, Sara J Buhrlage, Jinhua Wang, Nathanael S Gray, Marie José Kersten, Steven P Treon, Steven T Pals, Marcel Spaargaren
The dual HCK/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma. Leukemia 38 (7) (2024)
Hildo C Lantermans, Fangxue Ma, Annemieke Kuil, Sanne van Kesteren, Sevtap Yasinoglu, Guang Yang, Sara J Buhrlage, Jinhua Wang, Nathanael S Gray, Marie José Kersten, Steven P Treon, Steven T Pals, Marcel Spaargaren
The dual HCK/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma. Leukemia 38 (7) (2024)
Hildo C Lantermans, Fangxue Ma, Annemieke Kuil, Sanne van Kesteren, Sevtap Yasinoglu, Guang Yang, Sara J Buhrlage, Jinhua Wang, Nathanael S Gray, Marie José Kersten, Steven P Treon, Steven T Pals, Marcel Spaargaren
The dual HCK/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma. Leukemia 38 (7) (2024)
Hildo C Lantermans, Fangxue Ma, Annemieke Kuil, Sanne van Kesteren, Sevtap Yasinoglu, Guang Yang, Sara J Buhrlage, Jinhua Wang, Nathanael S Gray, Marie José Kersten, Steven P Treon, Steven T Pals, Marcel Spaargaren
The dual HCK/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma. Leukemia 38 (7) (2024)
Hildo C Lantermans, Fangxue Ma, Annemieke Kuil, Sanne van Kesteren, Sevtap Yasinoglu, Guang Yang, Sara J Buhrlage, Jinhua Wang, Nathanael S Gray, Marie José Kersten, Steven P Treon, Steven T Pals, Marcel Spaargaren
The dual HCK/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma. Leukemia 38 (7) (2024)
Hildo C Lantermans, Fangxue Ma, Annemieke Kuil, Sanne van Kesteren, Sevtap Yasinoglu, Guang Yang, Sara J Buhrlage, Jinhua Wang, Nathanael S Gray, Marie José Kersten, Steven P Treon, Steven T Pals, Marcel Spaargaren
The dual HCK/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma. Leukemia (2024)
Wai Cheung Chan, Xiaoxi Liu, Robert S Magin, Nicholas M Girardi, Scott B Ficarro, Wanyi Hu, Maria I Tarazona Guzman, Cara A Starnbach, Alejandra Felix, Guillaume Adelmant, Anthony C Varca, Bin Hu, Ariana S Bratt, Ethan DaSilva, Nathan J Schauer, Isabella Jaen Maisonet, Emma K Dolen, Anthony X Ayala, Jarrod A Marto, Sara J Buhrlage
Accelerating inhibitor discovery for deubiquitinating enzymes. Nature communications 14 (1) (2023)
Wai Cheung Chan, Xiaoxi Liu, Robert S Magin, Nicholas M Girardi, Scott B Ficarro, Wanyi Hu, Maria I Tarazona Guzman, Cara A Starnbach, Alejandra Felix, Guillaume Adelmant, Anthony C Varca, Bin Hu, Ariana S Bratt, Ethan DaSilva, Nathan J Schauer, Isabella Jaen Maisonet, Emma K Dolen, Anthony X Ayala, Jarrod A Marto, Sara J Buhrlage
Accelerating inhibitor discovery for deubiquitinating enzymes. Nature communications 14 (1) (2023)
Wai Cheung Chan, Xiaoxi Liu, Robert S Magin, Nicholas M Girardi, Scott B Ficarro, Wanyi Hu, Maria I Tarazona Guzman, Cara A Starnbach, Alejandra Felix, Guillaume Adelmant, Anthony C Varca, Bin Hu, Ariana S Bratt, Ethan DaSilva, Nathan J Schauer, Isabella Jaen Maisonet, Emma K Dolen, Anthony X Ayala, Jarrod A Marto, Sara J Buhrlage
Accelerating inhibitor discovery for deubiquitinating enzymes. Nature communications 14 (1) (2023)
Wai Cheung Chan, Xiaoxi Liu, Robert S Magin, Nicholas M Girardi, Scott B Ficarro, Wanyi Hu, Maria I Tarazona Guzman, Cara A Starnbach, Alejandra Felix, Guillaume Adelmant, Anthony C Varca, Bin Hu, Ariana S Bratt, Ethan DaSilva, Nathan J Schauer, Isabella Jaen Maisonet, Emma K Dolen, Anthony X Ayala, Jarrod A Marto, Sara J Buhrlage
Accelerating inhibitor discovery for deubiquitinating enzymes. Nature communications 14 (1) (2023)
Laura M Doherty, Caitlin E Mills, Sarah A Boswell, Xiaoxi Liu, Charles Tapley Hoyt, Benjamin M Gyori, Sara J Buhrlage, Peter Karl Sorger
Integrating multi-omics data reveals function and therapeutic potential of deubiquitinating enzymes. eLife 11 (2022)
He Zhu, J Scott Mellors, Wai Cheung Chan, J Will Thompson, Scott B Ficarro, Isidoro Tavares, Ariana S Bratt, Jens Decker, Michael Krause, Gary Kruppa, Sara J Buhrlage, Jarrod A Marto
On-Chip Preconcentration Microchip Capillary Electrophoresis Based CE-PRM-LIVE for High-Throughput Selectivity Profiling of Deubiquitinase Inhibitors. Analytical chemistry 94 (27) (2022)
Jing Yang, Ellen L Weisberg, Shuang Qi, Wei Ni, Husheng Mei, Zuowei Wang, Chengcheng Meng, Shengzhe Zhang, Mingqi Hou, Ziping Qi, Aoli Wang, Yunyun Jiang, Zongru Jiang, Tao Huang, Qingwang Liu, Robert S Magin, Laura Doherty, Wenchao Wang, Jing Liu, Sara J Buhrlage, Qing-Song Liu, James D Griffin
Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2. Leukemia 36 (4) (2022)
Jing Yang, Ellen L Weisberg, Xiaoxi Liu, Robert S Magin, Wai Cheung Chan, Bin Hu, Nathan J Schauer, Shengzhe Zhang, Ilaria Lamberto, Laura Doherty, Chengcheng Meng, Martin Sattler, Lucia Cabal-Hierro, Eric Winer, Richard Stone, Jarrod A Marto, James D Griffin, Sara J Buhrlage
Small molecule inhibition of deubiquitinating enzyme JOSD1 as a novel targeted therapy for leukemias with mutant JAK2. Leukemia (2021)
Nathan J Schauer, Robert S Magin, Xiaoxi Liu, Laura M Doherty, Sara J Buhrlage
Advances in Discovering Deubiquitinating Enzyme (DUB) Inhibitors. Journal of medicinal chemistry 63 (6) (2019)